Cargando…

Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS

Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic infection that emerged in the Middle East in 2012. Symptoms range from mild to severe and include both respiratory and gastrointestinal illnesses. The virus is mainly present in camel populations with occasional zoonotic spill ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljabr, Waleed, Alruwaili, Muhannad, Penrice-Randal, Rebekah, Alrezaihi, Abdulrahman, Harrison, Abbie Jasmine, Ryan, Yan, Bentley, Eleanor, Jones, Benjamin, Alhatlani, Bader Y., AlShahrani, Dayel, Mahmood, Zana, Rickett, Natasha Y., Alosaimi, Bandar, Naeem, Asif, Alamri, Saad, Alsran, Hadel, Hamed, Maaweya E., Dong, Xiaofeng, Assiri, Abdullah M., Alrasheed, Abdullah R., Hamza, Muaawia, Carroll, Miles W., Gemmell, Matthew, Darby, Alistair, Donovan-Banfield, I’ah, Stewart, James P., Matthews, David A., Davidson, Andrew D., Hiscox, Julian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386452/
https://www.ncbi.nlm.nih.gov/pubmed/34287009
http://dx.doi.org/10.1128/mSphere.00219-21
_version_ 1783742265177407488
author Aljabr, Waleed
Alruwaili, Muhannad
Penrice-Randal, Rebekah
Alrezaihi, Abdulrahman
Harrison, Abbie Jasmine
Ryan, Yan
Bentley, Eleanor
Jones, Benjamin
Alhatlani, Bader Y.
AlShahrani, Dayel
Mahmood, Zana
Rickett, Natasha Y.
Alosaimi, Bandar
Naeem, Asif
Alamri, Saad
Alsran, Hadel
Hamed, Maaweya E.
Dong, Xiaofeng
Assiri, Abdullah M.
Alrasheed, Abdullah R.
Hamza, Muaawia
Carroll, Miles W.
Gemmell, Matthew
Darby, Alistair
Donovan-Banfield, I’ah
Stewart, James P.
Matthews, David A.
Davidson, Andrew D.
Hiscox, Julian A.
author_facet Aljabr, Waleed
Alruwaili, Muhannad
Penrice-Randal, Rebekah
Alrezaihi, Abdulrahman
Harrison, Abbie Jasmine
Ryan, Yan
Bentley, Eleanor
Jones, Benjamin
Alhatlani, Bader Y.
AlShahrani, Dayel
Mahmood, Zana
Rickett, Natasha Y.
Alosaimi, Bandar
Naeem, Asif
Alamri, Saad
Alsran, Hadel
Hamed, Maaweya E.
Dong, Xiaofeng
Assiri, Abdullah M.
Alrasheed, Abdullah R.
Hamza, Muaawia
Carroll, Miles W.
Gemmell, Matthew
Darby, Alistair
Donovan-Banfield, I’ah
Stewart, James P.
Matthews, David A.
Davidson, Andrew D.
Hiscox, Julian A.
author_sort Aljabr, Waleed
collection PubMed
description Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic infection that emerged in the Middle East in 2012. Symptoms range from mild to severe and include both respiratory and gastrointestinal illnesses. The virus is mainly present in camel populations with occasional zoonotic spill over into humans. The severity of infection in humans is influenced by numerous factors, and similar to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), underlying health complications can play a major role. Currently, MERS-CoV and SARS-CoV-2 are coincident in the Middle East and thus a rapid way of sequencing MERS-CoV to derive genotype information for molecular epidemiology is needed. Additionally, complicating factors in MERS-CoV infections are coinfections that require clinical management. The ability to rapidly characterize these infections would be advantageous. To rapidly sequence MERS-CoV, an amplicon-based approach was developed and coupled to Oxford Nanopore long read length sequencing. This and a metagenomic approach were evaluated with clinical samples from patients with MERS. The data illustrated that whole-genome or near-whole-genome information on MERS-CoV could be rapidly obtained. This approach provided data on both consensus genomes and the presence of minor variants, including deletion mutants. The metagenomic analysis provided information of the background microbiome. The advantage of this approach is that insertions and deletions can be identified, which are the major drivers of genotype change in coronaviruses. IMPORTANCE Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in late 2012 in Saudi Arabia. The virus is a serious threat to people not only in the Middle East but also in the world and has been detected in over 27 countries. MERS-CoV is spreading in the Middle East and neighboring countries, and approximately 35% of reported patients with this virus have died. This is the most severe coronavirus infection so far described. Saudi Arabia is a destination for many millions of people in the world who visit for religious purposes (Umrah and Hajj), and so it is a very vulnerable area, which imposes unique challenges for effective control of this epidemic. The significance of our study is that clinical samples from patients with MERS were used for rapid in-depth sequencing and metagenomic analysis using long read length sequencing.
format Online
Article
Text
id pubmed-8386452
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-83864522021-09-09 Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS Aljabr, Waleed Alruwaili, Muhannad Penrice-Randal, Rebekah Alrezaihi, Abdulrahman Harrison, Abbie Jasmine Ryan, Yan Bentley, Eleanor Jones, Benjamin Alhatlani, Bader Y. AlShahrani, Dayel Mahmood, Zana Rickett, Natasha Y. Alosaimi, Bandar Naeem, Asif Alamri, Saad Alsran, Hadel Hamed, Maaweya E. Dong, Xiaofeng Assiri, Abdullah M. Alrasheed, Abdullah R. Hamza, Muaawia Carroll, Miles W. Gemmell, Matthew Darby, Alistair Donovan-Banfield, I’ah Stewart, James P. Matthews, David A. Davidson, Andrew D. Hiscox, Julian A. mSphere Research Article Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic infection that emerged in the Middle East in 2012. Symptoms range from mild to severe and include both respiratory and gastrointestinal illnesses. The virus is mainly present in camel populations with occasional zoonotic spill over into humans. The severity of infection in humans is influenced by numerous factors, and similar to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), underlying health complications can play a major role. Currently, MERS-CoV and SARS-CoV-2 are coincident in the Middle East and thus a rapid way of sequencing MERS-CoV to derive genotype information for molecular epidemiology is needed. Additionally, complicating factors in MERS-CoV infections are coinfections that require clinical management. The ability to rapidly characterize these infections would be advantageous. To rapidly sequence MERS-CoV, an amplicon-based approach was developed and coupled to Oxford Nanopore long read length sequencing. This and a metagenomic approach were evaluated with clinical samples from patients with MERS. The data illustrated that whole-genome or near-whole-genome information on MERS-CoV could be rapidly obtained. This approach provided data on both consensus genomes and the presence of minor variants, including deletion mutants. The metagenomic analysis provided information of the background microbiome. The advantage of this approach is that insertions and deletions can be identified, which are the major drivers of genotype change in coronaviruses. IMPORTANCE Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in late 2012 in Saudi Arabia. The virus is a serious threat to people not only in the Middle East but also in the world and has been detected in over 27 countries. MERS-CoV is spreading in the Middle East and neighboring countries, and approximately 35% of reported patients with this virus have died. This is the most severe coronavirus infection so far described. Saudi Arabia is a destination for many millions of people in the world who visit for religious purposes (Umrah and Hajj), and so it is a very vulnerable area, which imposes unique challenges for effective control of this epidemic. The significance of our study is that clinical samples from patients with MERS were used for rapid in-depth sequencing and metagenomic analysis using long read length sequencing. American Society for Microbiology 2021-07-21 /pmc/articles/PMC8386452/ /pubmed/34287009 http://dx.doi.org/10.1128/mSphere.00219-21 Text en Copyright © 2021 Aljabr et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Aljabr, Waleed
Alruwaili, Muhannad
Penrice-Randal, Rebekah
Alrezaihi, Abdulrahman
Harrison, Abbie Jasmine
Ryan, Yan
Bentley, Eleanor
Jones, Benjamin
Alhatlani, Bader Y.
AlShahrani, Dayel
Mahmood, Zana
Rickett, Natasha Y.
Alosaimi, Bandar
Naeem, Asif
Alamri, Saad
Alsran, Hadel
Hamed, Maaweya E.
Dong, Xiaofeng
Assiri, Abdullah M.
Alrasheed, Abdullah R.
Hamza, Muaawia
Carroll, Miles W.
Gemmell, Matthew
Darby, Alistair
Donovan-Banfield, I’ah
Stewart, James P.
Matthews, David A.
Davidson, Andrew D.
Hiscox, Julian A.
Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS
title Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS
title_full Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS
title_fullStr Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS
title_full_unstemmed Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS
title_short Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS
title_sort amplicon and metagenomic analysis of middle east respiratory syndrome (mers) coronavirus and the microbiome in patients with severe mers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386452/
https://www.ncbi.nlm.nih.gov/pubmed/34287009
http://dx.doi.org/10.1128/mSphere.00219-21
work_keys_str_mv AT aljabrwaleed ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT alruwailimuhannad ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT penricerandalrebekah ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT alrezaihiabdulrahman ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT harrisonabbiejasmine ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT ryanyan ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT bentleyeleanor ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT jonesbenjamin ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT alhatlanibadery ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT alshahranidayel ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT mahmoodzana ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT rickettnatashay ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT alosaimibandar ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT naeemasif ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT alamrisaad ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT alsranhadel ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT hamedmaaweyae ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT dongxiaofeng ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT assiriabdullahm ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT alrasheedabdullahr ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT hamzamuaawia ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT carrollmilesw ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT gemmellmatthew ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT darbyalistair ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT donovanbanfieldiah ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT stewartjamesp ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT matthewsdavida ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT davidsonandrewd ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers
AT hiscoxjuliana ampliconandmetagenomicanalysisofmiddleeastrespiratorysyndromemerscoronavirusandthemicrobiomeinpatientswithseveremers